These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 17392712)

  • 1. How can we improve clinical trials?
    Kaplan RS
    Nat Clin Pract Oncol; 2007 Apr; 4(4):206-7. PubMed ID: 17392712
    [No Abstract]   [Full Text] [Related]  

  • 2. Early average change in tumor size in a phase 2 trial: efficient endpoint or false promise?
    Rubinstein LV; Dancey JE; Korn EL; Smith MA; Wright JJ
    J Natl Cancer Inst; 2007 Oct; 99(19):1422-3. PubMed ID: 17895470
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II studies of modern drugs directed against new targets: if you are fazed, too, then resist RECIST.
    Ratain MJ; Eckhardt SG
    J Clin Oncol; 2004 Nov; 22(22):4442-5. PubMed ID: 15483011
    [No Abstract]   [Full Text] [Related]  

  • 4. Controversy trails adaptive clinical trials.
    Goozner M
    J Natl Cancer Inst; 2012 Sep; 104(18):1347-8. PubMed ID: 22984199
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials of novel and targeted therapies: endpoints, trial design, and analysis.
    Suman VJ; Dueck A; Sargent DJ
    Cancer Invest; 2008 Jun; 26(5):439-44. PubMed ID: 18568764
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
    Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
    Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
    [No Abstract]   [Full Text] [Related]  

  • 7. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Design and endpoints of clinical trials in hepatocellular carcinoma.
    Di Maio M; Daniele B; Gallo C; Perrone F
    J Natl Cancer Inst; 2008 Nov; 100(21):1557; author reply 1557-8. PubMed ID: 18957679
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical trial designs for multiple myeloma.
    Hoering A; Crowley J
    Clin Adv Hematol Oncol; 2007 Apr; 5(4):309-16. PubMed ID: 17607290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An examination of the efficiency of the sequential parallel design in psychiatric clinical trials.
    Tamura RN; Huang X
    Clin Trials; 2007; 4(4):309-17. PubMed ID: 17848492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rating rater improvement: a method for estimating increased effect size and reduction of clinical trial costs.
    Cogger KO
    J Clin Psychopharmacol; 2007 Aug; 27(4):418-20. PubMed ID: 17632240
    [No Abstract]   [Full Text] [Related]  

  • 12. New criteria for measuring tumor size ease workloads in clinical trials.
    McBride D
    ONS Connect; 2009 May; 24(5):21. PubMed ID: 19489465
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials with allergen products--statistical considerations.
    Volkers P
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):172-80; discussion 181. PubMed ID: 17393737
    [No Abstract]   [Full Text] [Related]  

  • 14. Leaders worry that U.S. is losing edge on cancer clinical trials.
    Twombly R
    J Natl Cancer Inst; 2008 Sep; 100(17):1196-9. PubMed ID: 18728275
    [No Abstract]   [Full Text] [Related]  

  • 15. Next steps in clinical trial redesign.
    Nicholas J
    J Natl Cancer Inst; 2012 Jan; 104(2):90-2. PubMed ID: 22215851
    [No Abstract]   [Full Text] [Related]  

  • 16. Should insurance be responsible for the cost of care while a patient is enrolled in a clinical trial?
    Weiss PA
    Clin J Oncol Nurs; 2008 Feb; 12(1):153-4. PubMed ID: 18258585
    [No Abstract]   [Full Text] [Related]  

  • 17. Approaches vary for clinical trials in developing countries.
    Hayasaka E
    J Natl Cancer Inst; 2005 Oct; 97(19):1401-3. PubMed ID: 16204687
    [No Abstract]   [Full Text] [Related]  

  • 18. Pros and cons of composite endpoints in anesthesia trials.
    Myles PS; Devereaux PJ
    Anesthesiology; 2010 Oct; 113(4):776-8. PubMed ID: 20808209
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical cancer research 2001: new agents and therapies.
    Verweij J; de Vries EG
    Drug Resist Updat; 2001 Aug; 4(4):217-23. PubMed ID: 11991676
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trial design issues in the era of targeted therapies.
    Schiller JH
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4281s-4282s. PubMed ID: 15217975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.